Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 16
2002 20
2003 37
2004 52
2005 47
2006 44
2007 75
2008 69
2009 75
2010 86
2011 91
2012 90
2013 82
2014 59
2015 72
2016 70
2017 70
2018 86
2019 81
2020 82
2021 63
2022 77
2023 100
2024 83

Text availability

Article attribute

Article type

Publication date

Search Results

1,627 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug Conjugate Targets, Drugs, and Linkers.
Teicher BA, Morris J. Teicher BA, et al. Curr Cancer Drug Targets. 2022;22(6):463-529. doi: 10.2174/1568009622666220224110538. Curr Cancer Drug Targets. 2022. PMID: 35209819 Review.
Resistance of Lenvatinib in Hepatocellular Carcinoma.
Guo J, Zhao J, Xu Q, Huang D. Guo J, et al. Curr Cancer Drug Targets. 2022;22(11):865-878. doi: 10.2174/1568009622666220428111327. Curr Cancer Drug Targets. 2022. PMID: 36267045 Review.
Oxidative Stress and Cancer: The Role of Nrf2.
Sajadimajd S, Khazaei M. Sajadimajd S, et al. Curr Cancer Drug Targets. 2018;18(6):538-557. doi: 10.2174/1568009617666171002144228. Curr Cancer Drug Targets. 2018. PMID: 28969555 Review.
Current Cancer Drug Development Strategies.
Shao J, Gao Y. Shao J, et al. Curr Cancer Drug Targets. 2019;19(4):243-244. doi: 10.2174/156800961904190321125849. Curr Cancer Drug Targets. 2019. PMID: 30968768 No abstract available.
Editorial: Cancer Epigenetics.
Ahmad A. Ahmad A. Curr Cancer Drug Targets. 2018;18(1):3-4. doi: 10.2174/156800961801171208144307. Curr Cancer Drug Targets. 2018. PMID: 29517470 No abstract available.
1,627 results